LDLR and atherosclerosis: In order to overcome this limitation, we tested whether a gene therapy approach that reintroduces LDL receptors (LDLR) into any genetically altered mouse on the Ldlr-/- background could be adapted to the study of acute atherosclerosis regression in diabetes and other metabolic perturbations.